CAPSTAR 11.4mg for Cats & Small Dogs are tablets designed to combat flea infestations in cats and small dogs, containing nitenpyram as the active ingredient. This neonicotinoid inhibits the transmission of excitation, which in turn leads to the death of adult fleas.

CAPSTAR 11.4mg for Cats & Small Dogs at a glance:

• Tablets to combat flea infestations in cats and small dogs weighing 1 - 11 kg over the age of 4 weeks
• Oral tablets with the active ingredient nitenpyram: to support the treatment of flea infestations
  • Kills fleas (Ctenocephalides felis): effects on fleas can be observed as early as 15 to 30 minutes after administration. These occur simultaneously with the fleas' first blood meal once sufficient blood levels have been reached in the host animal. 95 % to 100 % efficacy is observed within the first 6 hours, and 100 % efficacy is achieved within 24 hours without residual activity.
• Further information:
  • Use during pregnancy and lactation: nitenpyram can be administered safely during pregnancy and lactation. Studies in laboratory animals (rats and rabbits) showed no signs of teratogenic or foetotoxic effects, and tolerability has been demonstrated in pregnant and lactating cats and dogs.

Contraindications:
According to the manufacturer, there are no known contraindications.

Side effects:
Pets may experience increased itching in the first hour after administering CAPSTAR 11.4mg for Cats & Small Dogs. This effect is caused by fleas reacting to the product. In very rare cases, a dog may experience temporary hyperactivity, panting, vocalisation and excessive grooming/licking. Very rarely, transient neurological symptoms such as muscle tremors, ataxia and convulsions have been reported.

The frequency of side effects is defined as follows:The Federal Office of Consumer Protection and Food Safety, Mauerstraße 39-42, 10117 Berlin or the pharmaceutical company should be notified of any adverse reactions.

Interactions with other medicinal products:
None known. In clinical studies, no adverse drug reactions were observed when nitenpyram was used alongside other veterinary products, including common flea products, anthelmintics, vaccines or antibiotics.

For risks and side effects, please read the enclosed leaflet and consult your veterinarian or pharmacist.

For further information on pharmaceutical products sold through our pharmacy, please contact us at: .

Marketing authorisation holder in Germany: Elanco GmbH, Heinz‑Lohmann-Str. 4, D-27472 Cuxhaven
Ingredients:
1 tablet contains:
Active ingredient:
Nitenpyram (11.4mg)

Other ingredients:
Microcrystalline cellulose, maize starch, lactose monohydrate, anhydrous silica, magnesium stearate.

This product is a pharmaceutical product.
Dosage for each animal species, type and duration of use:

Method of administration:
Tablets to be administered with or without food.

Dosage:
The minimum effect dose is 1mg/kg bodyweight with the following recommendations:
If a flea infestation is detected, cats and small dogs with a body weight between 1kg and 11kg should be given 1 tablet of CAPSTAR 11.4mg. The frequency of treatment depends on the degree of infestation. In severe flea infestations, it may be necessary to treat the animals every day or every other day until the flea infestation is under control. Treatment can be resumed if fleas reappear. No more than one treatment per day should be given.

Instructions for correct use:
To improve palatability, the tablets can be added to a small amount of food.
CAPSTAR has no long-term effect. To prevent re-infestation, appropriate treatment to control immature stages of the flea life cycle is recommended. The treating veterinarian should determine an appropriate treatment programme.

Special warnings
Special precautions for use in animals:
Do not use in animals younger than 4 weeks of age or weighing less than 1kg as these groups of animals have not been studied.
Overdoses:
Nitenpyram is well tolerated by the target species. Overdoses of up to 50mg/kg in cats and up to 70mg/kg in dogs were asymptomatic.
Side effects such as salivation, vomiting, soft faeces, cramps or reduced activity are only observed at higher doses. Their severity increases with increasing doses. The symptoms disappear quickly and recovery is complete within 24 hours of the overdose due to the rapid elimination of Nitenpyram. No clinically significant treatment-related adverse reactions have been observed with daily dosing for 6 months in cats and dogs.
Special precautions for the user:
According to the manufacturer, no special precautions for the user are known.